Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,446 public trials 167 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Heparin or Enoxaparin in Patients With Cancer

NCT00004875

Conditions
Burkitt Lymphoma, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States
  • Evanston Northwestern Health Care Evanston, Illinois, United States
View Trial Details
Completed

SPC2996 in Chronic Lymphocytic Leukaemia

NCT00285103

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Holden Comprehensive Cancer Center, Univ. of Iowa Iowa City, Iowa, United States
  • Rigshospitalet Copenhagen, Denmark
  • KAS Herlev Herlev, Denmark
  • Vejle Sygehus Vejle, Denmark
View Trial Details
Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

NCT00361049

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +84 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • University Suburban Health Center Cleveland, Ohio, United States
View Trial Details
Completed

Assess the Oral Bioavailability of New ABT-263 Formulations

NCT00743028

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Site Reference ID/Investigator# 10281 Encinitas, California, United States
  • Site Reference ID/Investigator# 10282 Santa Monica, California, United States
  • Site Reference ID/Investigator# 16341 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 9441 Lebanon, New Hampshire, United States
View Trial Details

Related conditions